|
|
Volumn 59, Issue 6, 2001, Pages 286-291
|
|
Clinical experience with Sandostatin LAR® in patients with acromegaly
a
a
a
a
a
|
|
Author keywords
Acromegaly; IGF 1; Long acting; Octreotide; Sandostatin LAR
|
|
Indexed keywords
ESTROGEN;
GROWTH HORMONE;
HYDROCORTISONE;
LEVOTHYROXINE;
LONG ACTING DRUG;
OCTREOTIDE;
SOMATOMEDIN;
TESTOSTERONE;
ACROMEGALY;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG EFFECT;
FEMALE;
HEADACHE;
HUMAN;
IMMUNORADIOMETRIC ASSAY;
IRRADIATION;
LONG TERM CARE;
MALE;
PROTEIN BLOOD LEVEL;
QUANTITATIVE ASSAY;
SYMPTOM;
TRANSSPHENOIDAL SURGERY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ACROMEGALY;
ADULT;
AGED;
FEMALE;
HORMONES;
HUMANS;
MALE;
MIDDLE AGED;
OCTREOTIDE;
|
|
EID: 0035667059
PISSN: 03002977
EISSN: None
Source Type: Journal
DOI: 10.1016/S0300-2977(01)00171-1 Document Type: Article |
|
Times cited : (8)
|
|
References (14)
|
